These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 30607785)

  • 1. Comparison of quality of life measurements: EQ-5D-5L versus disease/treatment-specific measures in pulmonary embolism and deep vein thrombosis.
    Chuang LH; Cohen AT; Agnelli G; Gumbs PD; Bauersachs R; Kroep S; Gitt AK; Monreal M; Willich SN; van Hout B
    Qual Life Res; 2019 May; 28(5):1155-1177. PubMed ID: 30607785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric performance assessment of Malay and Malaysian English version of EQ-5D-5L in the Malaysian population.
    Shafie AA; Vasan Thakumar A; Lim CJ; Luo N
    Qual Life Res; 2019 Jan; 28(1):153-162. PubMed ID: 30317426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
    Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
    Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The VEINES-QOL/Sym questionnaire is a reliable and valid disease-specific quality of life measure for deep vein thrombosis in elderly patients.
    Méan M; Limacher A; Kahn SR; Aujesky D
    Qual Life Res; 2014 Nov; 23(9):2463-71. PubMed ID: 24791928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric properties of the EQ-5D-5L in patients with hip or knee osteoarthritis: reliability, validity and responsiveness.
    Bilbao A; García-Pérez L; Arenaza JC; García I; Ariza-Cardiel G; Trujillo-Martín E; Forjaz MJ; Martín-Fernández J
    Qual Life Res; 2018 Nov; 27(11):2897-2908. PubMed ID: 29978346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late consequences of venous thromboembolism: Measuring quality of life after deep vein thrombosis and pulmonary embolism.
    Ghanima W; Wik HS; Tavoly M; Enden T; Jelsness-Jørgensen LP
    Thromb Res; 2018 Apr; 164():170-176. PubMed ID: 28760416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity and measurement equivalence of EQ-5D-5L questionnaire among heart failure patients in Malaysia: a cohort study.
    Kuan WC; Chee KH; Kasim S; Lim KK; Dujaili JA; Lee KK; Teoh SL
    J Med Econ; 2024; 27(1):607-617. PubMed ID: 38557412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric Performance Comparison of the Adapted versus Original Versions of the EQ-5D-Y-3L and -Y-5L in Proxy Respondents for 2- to 4-Year-Olds.
    van Heusden A; Rivero-Arias O; Herdman M; Hiscock H; Devlin N; Dalziel K;
    Pharmacoeconomics; 2024 Jun; 42(Suppl 1):129-145. PubMed ID: 38238604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
    Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
    J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in psoriasis.
    Yfantopoulos J; Chantzaras A; Kontodimas S
    Arch Dermatol Res; 2017 Jul; 309(5):357-370. PubMed ID: 28528371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the EQ-5D-5L and stroke impact scale 2.0 in stroke patients: an analysis of measurement properties.
    Schmidt J; Düvel JA; Elkenkamp S; Greiner W
    Health Qual Life Outcomes; 2024 Jun; 22(1):45. PubMed ID: 38835023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the psychometric properties of EQ-5D-3L and EQ-5D-5L proxy ratings by informal caregivers and a health professional for people with dementia.
    Michalowsky B; Hoffmann W; Mohr W; Rädke A; Xie F
    Health Qual Life Outcomes; 2022 Oct; 20(1):140. PubMed ID: 36199138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation and comparison of 15-D and EQ-5D-5L instruments in a Spanish Parkinson's disease population sample.
    García-Gordillo M; del Pozo-Cruz B; Adsuar JC; Sánchez-Martínez FI; Abellán-Perpiñán JM
    Qual Life Res; 2014 May; 23(4):1315-26. PubMed ID: 24258254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy.
    Bhadhuri A; Kind P; Salari P; Jungo KT; Boland B; Byrne S; Hossmann S; Dalleur O; Knol W; Moutzouri E; O'Mahony D; Murphy KD; Wisselink L; Rodondi N; Schwenkglenks M
    Health Qual Life Outcomes; 2020 Sep; 18(1):317. PubMed ID: 32993637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the EQ-5D-3L and 5L versions in low back pain patients.
    Garratt AM; Furunes H; Hellum C; Solberg T; Brox JI; Storheim K; Johnsen LG
    Health Qual Life Outcomes; 2021 May; 19(1):155. PubMed ID: 34049574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn's disease.
    Rencz F; Lakatos PL; Gulácsi L; Brodszky V; Kürti Z; Lovas S; Banai J; Herszényi L; Cserni T; Molnár T; Péntek M; Palatka K
    Qual Life Res; 2019 Jan; 28(1):141-152. PubMed ID: 30225788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A head-to-head comparison of measurement properties of the EQ-5D-3L and EQ-5D-5L in acute myeloid leukemia patients.
    Yu H; Zeng X; Sui M; Liu R; Tan RL; Yang J; Huang W; Luo N
    Qual Life Res; 2021 Mar; 30(3):855-866. PubMed ID: 32965633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
    Cheung PWH; Wong CKH; Cheung JPY
    Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients.
    Pattanaphesaj J; Thavorncharoensap M
    Health Qual Life Outcomes; 2015 Feb; 13():14. PubMed ID: 25890017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients.
    Poór AK; Rencz F; Brodszky V; Gulácsi L; Beretzky Z; Hidvégi B; Holló P; Kárpáti S; Péntek M
    Qual Life Res; 2017 Dec; 26(12):3409-3419. PubMed ID: 28875430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.